First Trust Advisors LP Crispr Therapeutics Ag Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$45.39 - $59.0 $3.97 Million - $5.16 Million	-87,488 Reduced 90.76%	8,910 $404,000
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $4.19 Million - $6.53 Million	96,398 New	96,398 $5.41 Million
Q4 2022 Feb 09, 2023	SELL	$39.19 - $65.67 $2.17 Million - $3.63 Million	-55,307 Reduced 89.86%	6,238 $253,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $3.23 Million - $4.43 Million	52,930 Added 614.39%	61,545 $4.02 Million
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $10,029 - $17,128	232 Added 2.77%	8,615 $524,000
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $82,763 - $123,297	1,556 Added 22.79%	8,383 $526,000
Q4 2021 Feb 08, 2022	SELL	$70.09 - $111.29 $2.49 Million - $3.95 Million	-35,470 Reduced 83.86%	6,827 $517,000
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $4.66 Million - $6.63 Million	42,297 New	42,297 $4.73 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $3.12 Million - $5.02 Million	-30,979 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $3.77 Million - $7.15 Million	-34,023 Reduced 52.34%	30,979 $3.78 Million
Q4 2020 Feb 02, 2021	SELL	$79.67 - $173.23 $104,288 - $226,758	-1,309 Reduced 1.97%	65,002 $9.95 Million
Q3 2020 Nov 05, 2020	SELL	$78.5 - $100.64 $243,193 - $311,782	-3,098 Reduced 4.46%	66,311 $5.55 Million
Q2 2020 Jul 22, 2020	SELL	$38.5 - $76.05 $836,374 - $1.65 Million	-21,724 Reduced 23.84%	69,409 $5.1 Million
Q1 2020 May 06, 2020	BUY	$33.68 - $62.53 $3.07 Million - $5.7 Million	91,133 New	91,133 $3.87 Million
Q4 2019 Feb 03, 2020	SELL	$36.68 - $73.13 $883,437 - $1.76 Million	-24,085 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$40.99 - $52.56 $987,244 - $1.27 Million	24,085 New	24,085 $987,000
Q2 2019 Jul 30, 2019	SELL	$35.45 - $48.2 $882,421 - $1.2 Million	-24,892 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$28.02 - $40.87 $251,535 - $366,889	-8,977 Reduced 26.51%	24,892 $889,000
Q4 2018 Feb 07, 2019	SELL	$22.73 - $42.34 $1.35 Million - $2.52 Million	-59,478 Reduced 63.72%	33,869 $968,000
Q3 2018 Oct 25, 2018	BUY	$44.35 - $65.71 $367,883 - $545,064	8,295 Added 9.75%	93,347 $4.14 Million
Q2 2018 Aug 02, 2018	BUY	$42.62 - $73.59 $3.62 Million - $6.26 Million	85,052 New	85,052 $5 Million

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$380 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$359 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$143 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$142 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$142 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account